Amsterdam, the Netherlands, February 5, 2021 - LSP, one of Europe’s leading life sciences and healthcare investors, today announced the public offering of the shares of Pharvaris NV on Nasdaq. Pharvaris N.V. (“Pha [...]
Amsterdam, the Netherlands - January 20, 2021: LSP, one of Europe’s leading life sciences and healthcare investors, today announced its investment in Neurent Medical, an Irish medical device company pioneering innov [...]
for $1 billion
Angelini Pharma and Arvelle Therapeutics have agreed on a definitive merger agreement valuing Arvelle Therapeutics at up to $960 million
Angelini Pharma will become a leading player [...]
Amsterdam, the Netherlands, February 5, 2021 - LSP, one of Europe’s leading life sciences and healthcare investors, today announced the public offering of the shares of Pharvaris NV on Nasdaq. Pharvaris N.V. (“Pha [...]
Amsterdam, the Netherlands - January 20, 2021: LSP, one of Europe’s leading life sciences and healthcare investors, today announced its investment in Neurent Medical, an Irish medical device company pioneering innov [...]
for $1 billion
Angelini Pharma and Arvelle Therapeutics have agreed on a definitive merger agreement valuing Arvelle Therapeutics at up to $960 million
Angelini Pharma will become a leading player [...]
Follow us
